Latest / Decera Clinical Education Oncology Podcast
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Germany
In this episode, Georgios Gakis, MD, and Mario Wolfgang Kramer, MD, PhD, discuss key data on immune checkpoint inhibitors for urothelial carcinoma informing their clinical practice in Germany. Topics include:
Guideline changes for first-line UC based on data from JAVELIN Bladder 100 trial on avelumab maintenance after chemotherapy
Results from IMvigor130 and KEYNOTE-361 trials on concurrent immune checkpoint inhibition plus chemotherapy
When to consider first-line treatment with immune checkpoint inhibitor monotherapy
Utility of PD-L1 as biomarker for immune checkpoint inhibitor–based therapy…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.